Literature DB >> 14610760

Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2004. Final rule with comment period.

.   

Abstract

This final rule will refine the resource-based practice expense relative value units (RVUs) and make other changes to Medicare Part B payment policy. The policy changes concern: Medicare Economic Index, practice expense for professional component services, definition of diabetes for diabetes self-management training, supplemental survey data for practice expense, geographic practice cost indices, and several coding issues. In addition, this rule updates the codes subject to the physician self-referral prohibition. We also make revisions to the sustainable growth rate and the anesthesia conversion factor. These changes will ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. We are also finalizing the calendar year (CY) 2003 interim RVUs and are issuing interim RVUs for new and revised procedure codes for CY 2004. As required by the statute, we are announcing that the physician fee schedule update for CY 2004 is -4.5 percent, the initial estimate of the sustainable growth rate for CY 2004 is 7.4 percent, and the conversion factor for CY 2004 is $35.1339. We published a proposed rule (68 FR 50428) in the Federal Register on Part B drug payment reform on August 20, 2003. This proposed rule would also make changes to Medicare payment for furnishing or administering certain drugs and biologicals. We have not finalized these proposals to take into account that the Congress is considering legislation that would address these issues. We will continue to monitor legislative activity that would reform the Medicare Part B drug payment system. If legislation is not enacted soon on this issue, we remain committed to completing the regulatory process.

Entities:  

Mesh:

Year:  2003        PMID: 14610760

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  13 in total

1.  Effects of physician payment reform on provision of home dialysis.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Am J Manag Care       Date:  2016-06-01       Impact factor: 2.229

2.  Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.

Authors:  Kevin F Erickson; Kelvin B Tan; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

3.  Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis.

Authors:  Kevin F Erickson; Matthew Mell; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2014-12-01       Impact factor: 10.121

4.  Evaluating the Evidence behind Policy Mandates in US Dialysis Care.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2018-11-02       Impact factor: 10.121

5.  Provider visit frequency and vascular access interventions in hemodialysis.

Authors:  Kevin F Erickson; Matthew W Mell; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237

6.  Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Am J Kidney Dis       Date:  2016-11-14       Impact factor: 8.860

7.  Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Forum Health Econ Policy       Date:  2014-01-01

8.  Physician visits and 30-day hospital readmissions in patients receiving hemodialysis.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

9.  Predictors of provider-patient visit frequency during hemodialysis.

Authors:  Yelena Slinin; Haifeng Guo; Suying Li; Jiannong Liu; Benjamin Morgan; Kristine Ensrud; David T Gilbertson; Allan J Collins; Areef Ishani
Journal:  Am J Nephrol       Date:  2013-07-17       Impact factor: 3.754

Review 10.  The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

Authors:  Rachael L DiSantostefano; Andrea K Biddle; John P Lavelle
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.